Kazuki Sawamoto
Asahikawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study.
Journal: Drug metabolism and pharmacokinetics
Published: September 06, 2024
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation.
Journal: Diabetology international
Published: May 16, 2023
A maternal high-fat diet induces fetal origins of NASH-HCC in mice.
Journal: Scientific reports
Published: October 01, 2021
Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
Journal: Biopharmaceutics & drug disposition
Published: November 06, 2017
PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration.
Journal: Journal of pharmaceutical health care and sciences
Published: June 12, 2015
Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
Journal: Journal of pharmaceutical sciences
Published: January 30, 2015
Mechanisms of lower maintenance dose of tacrolimus in obese patients.
Journal: Drug metabolism and pharmacokinetics
Published: March 28, 2014
Influence of long-term enteral nutrition on pharmacokinetics of digoxin in rats.
Journal: Drug metabolism and pharmacokinetics
Published: July 13, 2012
CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status.
Journal: Diabetes
Published: April 05, 2012
Disposition kinetics of taxanes in peritoneal dissemination.
Journal: Gastroenterology research and practice
Published: January 06, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026